Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: Summary of the results

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1374-1384

  Kovatchev, Boris ^a,b   Cobelli, Claudio ^c   Renard, Eric ^d   Anderson, Stacey ^a   Breton, Marc ^a   Patek, Stephen ^b   Clarke, William ^a   Bruttomesso, Daniela ^c   Maran, Alberto ^c   Costa, Silvana ^c   Avogaro, Angelo ^c   Man, Chiara Dalla ^c   Facchinetti, Andrea ^c   Magni, Lalo ^e   De Nicolao, Giuseppe ^e   Place, Jerome ^d   Farret, Anne ^d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIV MONTPELLIER   (France)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

Closed loop control; Continuous glucose monitoring; Type 1 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; BIOLOGICAL MODEL; BLOOD; CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; COMPUTER SIMULATION; DOSE CALCULATION; DRUG EFFECT; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; ITALY; MALE; METABOLISM; MIDDLE AGED; MONITORING; MULTICENTER STUDY; PILOT STUDY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; CHILD; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; DRUG DOSAGE CALCULATIONS; FEMALE; FRANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; ITALY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MONITORING, PHYSIOLOGIC; PANCREAS, ARTIFICIAL; PILOT PROJECTS; TIME FACTORS; TREATMENT OUTCOME; VIRGINIA; YOUNG ADULT;

EID: 79953021776     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400611     Document Type: Article

References (25)

1. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes. 1974;23(5):389-96.
2. Santiago JV, Clemens AH, Clarke WL, Kipnis DM. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes. 1979;28(1):71-84.
3. Parker RS, Doyle FJ 3rd, Peppas NA. A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng. 1999;46(2):148-57.
4. Renard E. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol. 2002;2(6):708-16.
5. Bellazzi R, Nucci G, Cobelli C. The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng Med Biol Mag. 2001;20(1):54-64.
6. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006;23(1):1-12.
7. Klonoff DC. The artificial pancreas: how sweet engineering will solve bitter problems. J Diabetes Sci Technol. 2007;1(1):72-81.
8. The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464-76.
9. Hovorka R, Chassin LJ, Wilinska ME, Canonico V, Akwi JA, Federici MO, Massi-Benedetti M, Hutzli I, Zaugg C, Kaufmann H, Both M, Vering T, Schaller HC, Schaupp L, Bodenlenz M, Pieber TR. Closing the loop: the adicol experience. Diabetes Technol Ther. 2004;6(3):307-18.
10. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50.
11. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
12. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010;375(9716):743-51.
13. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini Federici M, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas. 2004;25(4):905-20.
14. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Science Trans Med. 2010;2(27):27ra27.
15. Magni L, Raimondo DM, Bossi L, Man CD, De Nicolao G, Kovatchev B, Cobelli C. Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol. 2007;1(6):804-12.
16. Dassau E, Bequette BW, Buckingham BA, Doyle FJ 3rd. Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell. Diabetes Care. 2008;31(2):295-300.
17. Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP. Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther. 2009;11(2):93-7.
18. Owens C, Zisser H, Jovanovic L, Srinivasan B, Bonvin D, Doyle FJ 3rd. Run-to-run control of blood glucose concentrations for people with type 1 diabetes mellitus. IEEE Trans Biomed Eng. 2006;53(6):996-1005.
19. Palerm CC, Zisser H, Bevier WC, Jovanovic L, Doyle FJ 3rd. Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric. Diabetes Care. 2007;30(5):1131-6.
20. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2009;3(5):1031-8.
21. Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol. 2009;3(5):1014-21.
22. Dalla Man C, Rizza RA, Cobelli C. Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng. 2007;54(10):1740-9.
23. Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
24. Chan A, Breton MD, Kovatchev BP. Effects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels. J Diabetes Sci Technol. 2008;2(5):844-52.
25. Clarke W, Kovatchev B. Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther. 2009;11 Suppl 1:S45-54.